Persistence of HIV-1 Transmitted Drug Resistance Mutations

There are few data on the persistence of individual human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) mutations in the absence of selective drug pressure. We studied 313 patients in whom TDR mutations were detected at their first resistance test and who had a subsequent t...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 208; no. 9; pp. 1459 - 1463
Main Authors Castro, Hannah, Pillay, Deenan, Cane, Patricia, Asboe, David, Cambiano, Valentina, Phillips, Andrew, Dunn, David T.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract There are few data on the persistence of individual human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) mutations in the absence of selective drug pressure. We studied 313 patients in whom TDR mutations were detected at their first resistance test and who had a subsequent test performed while ART-naive. The rate at which mutations became undetectable was estimated using exponential regression accounting for interval censoring. Most thymidine analogue mutations (TAMs) and T215 revertants (but not T215F/Y) were found to be highly stable, with NNRTI and PI mutations being relatively less persistent. Our estimates are important for informing HIV transmission models.
AbstractList There are few data on the persistence of individual human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) mutations in the absence of selective drug pressure. We studied 313 patients in whom TDR mutations were detected at their first resistance test and who had a subsequent test performed while ART-naive. The rate at which mutations became undetectable was estimated using exponential regression accounting for interval censoring. Most thymidine analogue mutations (TAMs) and T215 revertants (but not T215F/Y) were found to be highly stable, with NNRTI and PI mutations being relatively less persistent. Our estimates are important for informing HIV transmission models.
Author Castro, Hannah
Phillips, Andrew
Pillay, Deenan
Cane, Patricia
Asboe, David
Dunn, David T.
Cambiano, Valentina
AuthorAffiliation 3 Virus Reference Department , Public Health England , London , United Kingdom
5 Research Department of Infection and Population Health , University College London , London , United Kingdom
1 Medical Research Council Clinical Trials Unit , London , United Kingdom
2 Division of Infection and Immunity , University College London , London , United Kingdom
4 Directorate of HIV Medicine and Sexual Health , Chelsea and Westminster Hospital , London , United Kingdom
AuthorAffiliation_xml – name: 4 Directorate of HIV Medicine and Sexual Health , Chelsea and Westminster Hospital , London , United Kingdom
– name: 2 Division of Infection and Immunity , University College London , London , United Kingdom
– name: 1 Medical Research Council Clinical Trials Unit , London , United Kingdom
– name: 5 Research Department of Infection and Population Health , University College London , London , United Kingdom
– name: 3 Virus Reference Department , Public Health England , London , United Kingdom
Author_xml – sequence: 1
  givenname: Hannah
  surname: Castro
  fullname: Castro, Hannah
– sequence: 2
  givenname: Deenan
  surname: Pillay
  fullname: Pillay, Deenan
– sequence: 3
  givenname: Patricia
  surname: Cane
  fullname: Cane, Patricia
– sequence: 4
  givenname: David
  surname: Asboe
  fullname: Asboe, David
– sequence: 5
  givenname: Valentina
  surname: Cambiano
  fullname: Cambiano, Valentina
– sequence: 6
  givenname: Andrew
  surname: Phillips
  fullname: Phillips, Andrew
– sequence: 7
  givenname: David T.
  surname: Dunn
  fullname: Dunn, David T.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27843973$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23904291$$D View this record in MEDLINE/PubMed
BookMark eNqF0c9rFDEUB_AgFbutHj0qcxF6mTYvv-NBkFZtoaJI9RoymaRmmc20SUbwv3eWWZf21FMO75OXvPc9QgdpTB6h14BPAWt6FlPoYzlbx0oZf4ZWwKlshQB6gFYYE9KC0voQHZWyxhgzKuQLdEioxoxoWKH3330usVSfnG_G0Fxe_Wqhuck2lU2s1ffNRZ5umx9-i-wWfZ2qrXFM5SV6HuxQ_KvdeYx-fv50c37ZXn_7cnX-8bp1nKra9hRr4IRACEK5EHTHoe8VxwBCAgEclGO2k0Rg3QNIrokXgsqAe6y6jtFj9GHpezd1G987n2q2g7nLcWPzXzPaaB5XUvxtbsc_hkqluYS5wcmuQR7vJ1-q2cTi_DDY5MepGBCcCaXn1TxNGaNUcVB0pu1CXR5LyT7sfwTYbKMxSzRmiWb2bx-Osdf_s5jBux2wxdkhzBm4-freScWoltuH3yxuXeqY93VGuMLz8ug_uw6jNA
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1007_s00705_015_2481_4
crossref_primary_10_1186_s12981_015_0046_y
crossref_primary_10_1093_ofid_ofz034
crossref_primary_10_3389_fviro_2023_1291996
crossref_primary_10_3851_IMP3349
crossref_primary_10_3851_IMP3105
crossref_primary_10_1016_j_jviromet_2016_04_007
crossref_primary_10_7448_IAS_19_1_20966
crossref_primary_10_1097_QAD_0000000000000768
crossref_primary_10_1097_MD_0000000000017585
crossref_primary_10_1128_JCM_00105_18
crossref_primary_10_1371_journal_pone_0206177
crossref_primary_10_3390_v13050879
crossref_primary_10_1186_s12977_014_0105_9
crossref_primary_10_1371_journal_pone_0209605
crossref_primary_10_1016_S2666_5247_20_30006_9
crossref_primary_10_1093_cid_civ393
crossref_primary_10_1098_rspb_2017_1619
crossref_primary_10_1128_JCM_00634_17
crossref_primary_10_1371_journal_pone_0205446
crossref_primary_10_12659_MSM_898656
crossref_primary_10_1111_hiv_12236
crossref_primary_10_1097_QAI_0000000000000502
crossref_primary_10_1097_QAI_0000000000000942
crossref_primary_10_1128_AAC_00539_19
crossref_primary_10_1093_jac_dkv120
crossref_primary_10_1093_ve_vex008
crossref_primary_10_1128_JCM_00030_16
crossref_primary_10_1097_QAI_0000000000002908
crossref_primary_10_1371_journal_pone_0218649
crossref_primary_10_3390_v15010107
crossref_primary_10_1093_cid_civ400
crossref_primary_10_1016_j_jphs_2018_11_016
crossref_primary_10_1016_j_meegid_2016_08_031
crossref_primary_10_3851_IMP2746
crossref_primary_10_1097_QAD_0000000000000811
crossref_primary_10_1371_journal_pone_0210559
crossref_primary_10_1097_QAI_0000000000002718
crossref_primary_10_1097_QCO_0000000000000136
crossref_primary_10_1111_hiv_12508
crossref_primary_10_3389_fpubh_2021_731280
crossref_primary_10_1093_molbev_msz131
crossref_primary_10_1093_jac_dkv171
crossref_primary_10_1016_j_jmii_2014_08_002
crossref_primary_10_1093_molbev_msy088
crossref_primary_10_1111_hiv_13038
crossref_primary_10_1186_s13104_020_05151_w
crossref_primary_10_1093_jac_dkw404
crossref_primary_10_1093_jac_dkv473
crossref_primary_10_1093_cid_ciab583
crossref_primary_10_1177_0956462415571671
crossref_primary_10_1093_jac_dku426
crossref_primary_10_1016_j_eclinm_2019_03_006
crossref_primary_10_1093_jac_dkx014
crossref_primary_10_2174_1570162X17666191128101426
crossref_primary_10_1093_jac_dky468
crossref_primary_10_3390_v15061244
crossref_primary_10_1371_journal_pone_0093537
crossref_primary_10_1016_j_idc_2019_05_001
crossref_primary_10_1371_journal_ppat_1004722
crossref_primary_10_1371_journal_pone_0170265
crossref_primary_10_1093_cid_ciw382
crossref_primary_10_1038_s41598_019_53520_8
crossref_primary_10_1111_hiv_12414
crossref_primary_10_3389_fpubh_2023_1179568
crossref_primary_10_1093_cid_ciy1048
crossref_primary_10_1007_s00705_017_3572_1
crossref_primary_10_1186_s12879_020_05124_1
crossref_primary_10_1186_s12879_021_06847_5
crossref_primary_10_1089_aid_2015_0225
crossref_primary_10_1128_cmr_00052_22
crossref_primary_10_1186_s12879_023_08649_3
crossref_primary_10_1097_QAD_0000000000001689
crossref_primary_10_1093_cid_ciy453
crossref_primary_10_1371_journal_pmed_1001810
crossref_primary_10_1186_s13104_018_3804_9
crossref_primary_10_1371_journal_ppat_1006895
crossref_primary_10_3389_fphar_2021_718763
crossref_primary_10_1097_QAI_0000000000002454
crossref_primary_10_1089_aid_2016_0152
Cites_doi 10.1086/510533
10.1097/QAI.0b013e3181bca669
10.1097/01.aids.0000131391.91468.ff
10.1016/S1473-3099(11)70032-9
10.1097/QAD.0b013e328344037a
10.1097/QAD.0b013e3280b07761
10.1128/JVI.72.5.3520-3523.1998
10.1038/srep00320
10.1371/journal.pone.0004724
10.1128/JVI.02712-06
10.1093/infdis/jiq167
10.1128/JVI.02579-07
10.1128/JVI.73.5.3744-3752.1999
10.1093/jac/dkr157
10.1177/135965350601100208
ContentType Journal Article
Contributor Kaye, Steve
Hale, Tony
Tandy, Richard
Greatorex, Jane
Rice, Philip
Tilston, Peter
Smit, Erasmus
Hué, Stéphane
Pillay, Deenan
Cane, Patricia
Webster, Daniel
Orkin, Chloe
Ashton, Lynn
Churchill, Duncan
Clark, Duncan
Kirk, Stuart
Templeton, Kate
Hay, Phillip
Rice, Phillip
Collins, Simon
Mackie, Nicola
Castro, Hannah
Payne, Brendan
Leigh-Brown, Andrew
Delpech, Valerie
Goldberg, David
Wildfire, Adrian
Zhang, Hongyi
Chadwick, David
Tong, William
Geretti, Anna Maria
Lazarus, Linda
Hale, Antony
Bibby, David
Aitken, Celia
Cox, Alison
Mbisa, Tamyo
Schmid, Matthias L
Asboe, David
Williams, Ian
Gunson, Rory
Paynter, Mary
Shepherd, Jill
Hopkins, Mark
Zuckerman, Mark
Fawcett, Tracy
Kellam, Paul
O'Shea, Siobhan
Garcia-Diaz, Ana
Mullen, Jane
Maclean, Alasdair
Contributor_xml – sequence: 1
  givenname: Celia
  surname: Aitken
  fullname: Aitken, Celia
– sequence: 2
  givenname: David
  surname: Asboe
  fullname: Asboe, David
– sequence: 3
  givenname: Daniel
  surname: Webster
  fullname: Webster, Daniel
– sequence: 4
  givenname: Patricia
  surname: Cane
  fullname: Cane, Patricia
– sequence: 5
  givenname: Hannah
  surname: Castro
  fullname: Castro, Hannah
– sequence: 6
  givenname: David
  surname: Chadwick
  fullname: Chadwick, David
– sequence: 7
  givenname: Duncan
  surname: Churchill
  fullname: Churchill, Duncan
– sequence: 8
  givenname: Duncan
  surname: Clark
  fullname: Clark, Duncan
– sequence: 9
  givenname: Simon
  surname: Collins
  fullname: Collins, Simon
– sequence: 10
  givenname: Valerie
  surname: Delpech
  fullname: Delpech, Valerie
– sequence: 11
  givenname: Anna Maria
  surname: Geretti
  fullname: Geretti, Anna Maria
– sequence: 12
  givenname: David
  surname: Goldberg
  fullname: Goldberg, David
– sequence: 13
  givenname: Antony
  surname: Hale
  fullname: Hale, Antony
– sequence: 14
  givenname: Stéphane
  surname: Hué
  fullname: Hué, Stéphane
– sequence: 15
  givenname: Steve
  surname: Kaye
  fullname: Kaye, Steve
– sequence: 16
  givenname: Paul
  surname: Kellam
  fullname: Kellam, Paul
– sequence: 17
  givenname: Linda
  surname: Lazarus
  fullname: Lazarus, Linda
– sequence: 18
  givenname: Andrew
  surname: Leigh-Brown
  fullname: Leigh-Brown, Andrew
– sequence: 19
  givenname: Nicola
  surname: Mackie
  fullname: Mackie, Nicola
– sequence: 20
  givenname: Chloe
  surname: Orkin
  fullname: Orkin, Chloe
– sequence: 21
  givenname: Philip
  surname: Rice
  fullname: Rice, Philip
– sequence: 22
  givenname: Deenan
  surname: Pillay
  fullname: Pillay, Deenan
– sequence: 23
  givenname: Erasmus
  surname: Smit
  fullname: Smit, Erasmus
– sequence: 24
  givenname: Kate
  surname: Templeton
  fullname: Templeton, Kate
– sequence: 25
  givenname: Peter
  surname: Tilston
  fullname: Tilston, Peter
– sequence: 26
  givenname: William
  surname: Tong
  fullname: Tong, William
– sequence: 27
  givenname: Ian
  surname: Williams
  fullname: Williams, Ian
– sequence: 28
  givenname: Hongyi
  surname: Zhang
  fullname: Zhang, Hongyi
– sequence: 29
  givenname: Mark
  surname: Zuckerman
  fullname: Zuckerman, Mark
– sequence: 30
  givenname: Jane
  surname: Greatorex
  fullname: Greatorex, Jane
– sequence: 31
  givenname: Adrian
  surname: Wildfire
  fullname: Wildfire, Adrian
– sequence: 32
  givenname: Siobhan
  surname: O'Shea
  fullname: O'Shea, Siobhan
– sequence: 33
  givenname: Jane
  surname: Mullen
  fullname: Mullen, Jane
– sequence: 34
  givenname: Tamyo
  surname: Mbisa
  fullname: Mbisa, Tamyo
– sequence: 35
  givenname: Alison
  surname: Cox
  fullname: Cox, Alison
– sequence: 36
  givenname: Richard
  surname: Tandy
  fullname: Tandy, Richard
– sequence: 37
  givenname: Tony
  surname: Hale
  fullname: Hale, Tony
– sequence: 38
  givenname: Tracy
  surname: Fawcett
  fullname: Fawcett, Tracy
– sequence: 39
  givenname: Mark
  surname: Hopkins
  fullname: Hopkins, Mark
– sequence: 40
  givenname: Lynn
  surname: Ashton
  fullname: Ashton, Lynn
– sequence: 41
  givenname: Ana
  surname: Garcia-Diaz
  fullname: Garcia-Diaz, Ana
– sequence: 42
  givenname: Jill
  surname: Shepherd
  fullname: Shepherd, Jill
– sequence: 43
  givenname: Matthias L
  surname: Schmid
  fullname: Schmid, Matthias L
– sequence: 44
  givenname: Brendan
  surname: Payne
  fullname: Payne, Brendan
– sequence: 45
  givenname: Phillip
  surname: Hay
  fullname: Hay, Phillip
– sequence: 46
  givenname: Phillip
  surname: Rice
  fullname: Rice, Phillip
– sequence: 47
  givenname: Mary
  surname: Paynter
  fullname: Paynter, Mary
– sequence: 48
  givenname: David
  surname: Bibby
  fullname: Bibby, David
– sequence: 49
  givenname: Stuart
  surname: Kirk
  fullname: Kirk, Stuart
– sequence: 50
  givenname: Alasdair
  surname: Maclean
  fullname: Maclean, Alasdair
– sequence: 51
  givenname: Rory
  surname: Gunson
  fullname: Gunson, Rory
Copyright Copyright © 2013 Oxford University Press on behalf of the Infectious Diseases Society of America
2014 INIST-CNRS
The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. 2013
Copyright_xml – notice: Copyright © 2013 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: 2014 INIST-CNRS
– notice: The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. 2013
CorporateAuthor UK Collaborative Group on HIV Drug Resistance
for the UK Collaborative Group on HIV Drug Resistance
CorporateAuthor_xml – name: UK Collaborative Group on HIV Drug Resistance
– name: for the UK Collaborative Group on HIV Drug Resistance
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7U9
H94
5PM
DOI 10.1093/infdis/jit345
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList
MEDLINE
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 1463
ExternalDocumentID 10_1093_infdis_jit345
23904291
27843973
42580592
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: MC_UU_12023/15
– fundername: Wellcome Trust
  grantid: 095831
– fundername: Medical Research Council
  grantid: MR/K006584/1
– fundername: Medical Research Council
  grantid: G0900274
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABTLG
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACPRK
ACUFI
ACUTO
ACYHN
ADACV
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DOOOF
DU5
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
~91
.55
.GJ
08R
3O-
41~
6.Y
69O
8W4
AABJS
AABMN
AAESY
AAIYJ
AANRK
AAPGJ
AAWDT
AAYOK
ABFLS
ABPTK
ABSAR
ABSMQ
ACFRR
ACIMA
ACPQN
ACUTJ
ADEIU
ADGIM
ADMTO
ADORX
ADQLU
ADZLD
AEKPW
AFFNX
AFHKK
AGKRT
AGVJH
AHGVY
AI.
AIKOY
AIMBJ
AQDSO
AQKUS
ASMCH
AWCFO
AZQFJ
BGYMP
BYORX
BZKNY
DNJUQ
DPORF
DPPUQ
DWIUU
EIHJH
G8K
HQ3
HTVGU
IQODW
J5H
MBLQV
MVM
N4W
NEJ
O~Y
P0-
PQEST
TMA
UMP
VH1
X7M
Y6R
ZA5
ZE2
ZGI
ZKG
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AASNB
AAYXX
CITATION
7X8
7U9
H94
5PM
ID FETCH-LOGICAL-c538t-d30915221ff68cff9b51dd85011671210f8c4ab72609d117592e6637f0d08bb43
ISSN 0022-1899
IngestDate Tue Sep 17 21:27:58 EDT 2024
Sat Aug 17 00:29:32 EDT 2024
Fri Aug 16 22:39:40 EDT 2024
Thu Sep 12 18:17:27 EDT 2024
Wed Oct 16 00:44:02 EDT 2024
Thu Nov 24 18:30:00 EST 2022
Sun Oct 20 12:49:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Virus
Infection
Resistance
HIV-1 virus
Retroviridae
Human immunodeficiency virus
Mutation
Lentivirus
HIV-1
persistence
mutations
transmitted
resistance
Language English
License CC BY 4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c538t-d30915221ff68cff9b51dd85011671210f8c4ab72609d117592e6637f0d08bb43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3789571
PMID 23904291
PQID 1443385183
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3789571
proquest_miscellaneous_1654689367
proquest_miscellaneous_1443385183
crossref_primary_10_1093_infdis_jit345
pubmed_primary_23904291
pascalfrancis_primary_27843973
jstor_primary_42580592
PublicationCentury 2000
PublicationDate 2013-11-01
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2013
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References van Maarseveen ( key 20180328160231_JIT345C5) 2007; 195
Bezemer ( key 20180328160231_JIT345C6) 2006; 11
Martinez-Picado ( key 20180328160231_JIT345C14) 1999; 73
Wagner ( key 20180328160231_JIT345C12) 2012; 2
Jain ( key 20180328160231_JIT345C2) 2011; 203
Pingen ( key 20180328160231_JIT345C4) 2011; 66
Wittkop ( key 20180328160231_JIT345C1) 2011; 11
Yerly ( key 20180328160231_JIT345C9) 1998; 72
Bennett ( key 20180328160231_JIT345C8) 2009; 4
Little ( key 20180328160231_JIT345C3) 2008; 82
Barbour ( key 20180328160231_JIT345C10) 2004; 18
Cong ( key 20180328160231_JIT345C13) 2006; 81
Varghese ( key 20180328160231_JIT345C15) 2009; 52
Phillips ( key 20180328160231_JIT345C11) 2011; 25
UK Collaborative Group on HIV Drug Resistance ( key 20180328160231_JIT345C7) 2007; 21
References_xml – volume: 195
  start-page: 399
  year: 2007
  ident: key 20180328160231_JIT345C5
  article-title: Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation
  publication-title: J Infect Dis
  doi: 10.1086/510533
  contributor:
    fullname: van Maarseveen
– volume: 52
  start-page: 309
  year: 2009
  ident: key 20180328160231_JIT345C15
  article-title: Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3181bca669
  contributor:
    fullname: Varghese
– volume: 18
  start-page: 1683
  year: 2004
  ident: key 20180328160231_JIT345C10
  article-title: Persistence of primary drug resistance among recently HIV-1 infected adults
  publication-title: AIDS
  doi: 10.1097/01.aids.0000131391.91468.ff
  contributor:
    fullname: Barbour
– volume: 11
  start-page: 363
  year: 2011
  ident: key 20180328160231_JIT345C1
  article-title: Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(11)70032-9
  contributor:
    fullname: Wittkop
– volume: 25
  start-page: 843
  year: 2011
  ident: key 20180328160231_JIT345C11
  article-title: Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
  publication-title: Aids
  doi: 10.1097/QAD.0b013e328344037a
  contributor:
    fullname: Phillips
– volume: 21
  start-page: 1035
  year: 2007
  ident: key 20180328160231_JIT345C7
  article-title: Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3280b07761
  contributor:
    fullname: UK Collaborative Group on HIV Drug Resistance
– volume: 72
  start-page: 3520
  year: 1998
  ident: key 20180328160231_JIT345C9
  article-title: Switch to unusual amino acids at Codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants
  publication-title: J Virol
  doi: 10.1128/JVI.72.5.3520-3523.1998
  contributor:
    fullname: Yerly
– volume: 2
  start-page: 1
  year: 2012
  ident: key 20180328160231_JIT345C12
  article-title: Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks
  publication-title: Sci Rep
  doi: 10.1038/srep00320
  contributor:
    fullname: Wagner
– volume: 4
  start-page: e4724
  year: 2009
  ident: key 20180328160231_JIT345C8
  article-title: Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0004724
  contributor:
    fullname: Bennett
– volume: 81
  start-page: 3037
  year: 2006
  ident: key 20180328160231_JIT345C13
  article-title: The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions
  publication-title: J Virol
  doi: 10.1128/JVI.02712-06
  contributor:
    fullname: Cong
– volume: 203
  start-page: 1174
  year: 2011
  ident: key 20180328160231_JIT345C2
  article-title: Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiq167
  contributor:
    fullname: Jain
– volume: 82
  start-page: 5510
  year: 2008
  ident: key 20180328160231_JIT345C3
  article-title: Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection
  publication-title: J Virol
  doi: 10.1128/JVI.02579-07
  contributor:
    fullname: Little
– volume: 73
  start-page: 3744
  year: 1999
  ident: key 20180328160231_JIT345C14
  article-title: Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
  publication-title: J Virol
  doi: 10.1128/JVI.73.5.3744-3752.1999
  contributor:
    fullname: Martinez-Picado
– volume: 66
  start-page: 1467
  year: 2011
  ident: key 20180328160231_JIT345C4
  article-title: Evolutionary pathways of transmitted drug-resistant HIV-1
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkr157
  contributor:
    fullname: Pingen
– volume: 11
  start-page: 173
  year: 2006
  ident: key 20180328160231_JIT345C6
  article-title: Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load
  publication-title: Antivir Ther
  doi: 10.1177/135965350601100208
  contributor:
    fullname: Bezemer
SSID ssj0004367
Score 2.4642568
Snippet There are few data on the persistence of individual human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) mutations in the absence of...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1459
SubjectTerms Adolescent
Adult
Anti-HIV Agents - pharmacology
Anti-HIV Agents - therapeutic use
Biological and medical sciences
Drug resistance
Drug Resistance, Viral - genetics
Female
Fundamental and applied biological sciences. Psychology
Genetic mutation
HIV
HIV 1
HIV Infections - drug therapy
HIV Infections - virology
HIV-1 - drug effects
HIV-1 - genetics
HIV/AIDS
Hospital units
Human immunodeficiency virus 1
Humans
Infections
Infectious diseases
Major and Brief Reports
Male
Medical sciences
Memory interference
Microbiology
Miscellaneous
Teaching hospitals
Virology
Viruses
Young Adult
Title Persistence of HIV-1 Transmitted Drug Resistance Mutations
URI https://www.jstor.org/stable/42580592
https://www.ncbi.nlm.nih.gov/pubmed/23904291
https://search.proquest.com/docview/1443385183
https://search.proquest.com/docview/1654689367
https://pubmed.ncbi.nlm.nih.gov/PMC3789571
Volume 208
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbQEIgXxAaDbDAFCfEWltQ_4vA2lY0yaYiHDfUtSuxYdBIZWtMH9tfvLpfE6SgIeIla13Lb-87nO_vuM2NvikrqsohNVMFiFglpVKSdqgCQTGWVFbJo93TPPqvZhTidy7kvIWirS5rynbnZWFfyP6hCG-CKVbL_gOwwKDTAa8AXnoAwPP8KY0xfR5hwcuKG_KevUUJ05d8XDbqSH65XbXIdOontDF41ox26S68pp2MCCUrPWi3705vB7Z4Wy4bqYmZFXfud5C94dREdx0NY7PVt2iXS0j0Ai2EFOFqWlIHoM-q7jYeEdxV4Q5i6uaBxbGwhzk003X_UG9tJrEdalY1MZyI6avCqe0uG7xcTT_RX0GSRhOHkctFwIqS8w5sNxkiD7wjL8_1JmklM9_w49-k_gqu0Z5LHH9nxr8LohzT2IY285q9QyirmzxZLmEKO7j7ZFJzczbEdOS3nT9jjDtXwiFRnm92r6h32gO4f_bnDHp51mRVP2fuRLoVXLmx1KRzpUoi6FHpdCgddesYuTo7Pp7Oou1cjMrC8NZHl4CSC3504p7RxLitlYq2W7ZkcEso5bURRphDqZhapXLNJBY5p6mIb67IUfJdt1Vd19YKFxjjjlMUdaSVi7gohXKoVj4W1AIAM2NteevkPok_JKe2B5yTmnMQcsN1WtkOvHr6AHawJe-iAJ-bgTPOAve6ln4NpxPMuUG6YJBDVCs4hotB_6oPFfOCzqzRgzwkx_w08Q3ctCVi6huXQAanZ1z-pF99ainae6kymyd7v_tU-e-Sn1Eu21Vyvqlfg3TblQaumt-Q7qEo
link.rule.ids 230,315,786,790,891,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Persistence+of+HIV-1+Transmitted+Drug+Resistance+Mutations&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Castro%2C+Hannah&rft.au=Pillay%2C+Deenan&rft.au=Cane%2C+Patricia&rft.au=Asboe%2C+David&rft.date=2013-11-01&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.volume=208&rft.issue=9&rft.spage=1459&rft.epage=1463&rft_id=info:doi/10.1093%2Finfdis%2Fjit345&rft.externalDocID=42580592
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon